Michael Wayne Kalb Amarin Corp Plcuk (AMRN) insider trading activity

Michael Wayne Kalb is SVP and CFO of AMARIN CORP PLCUK. Currently has a direct ownership of 337,314 shares of AMRN, which is worth approximately $155,164. The most recent transaction as insider was on Feb 25, 2021, when has been sold 43,395 shares (Ordinary Shares) at a price of $7.3 per share, resulting in proceeds of $316,784. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 337K

0% 3M change

0% 12M change

Total Value Held $155,164

Michael Wayne Kalb Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2021	SELL Payment of exercise price or tax liability	$316,784 $7.3 p/Share	43,395 Reduced 19.82%	175,529 Ordinary Shares
Feb 25 2021	BUY Exercise of conversion of derivative security	-	88,614 Added 28.81%	218,924 Ordinary Shares
Jan 29 2021	SELL Payment of exercise price or tax liability	$111,960 $7.5 p/Share	14,928 Reduced 10.28%	130,310 Ordinary Shares
Jan 29 2021	BUY Exercise of conversion of derivative security	-	41,789 Added 24.14%	131,350 Ordinary Shares
Dec 31 2020	SELL Payment of exercise price or tax liability	$7,835 $5.23 p/Share	1,498 Reduced 1.43%	103,449 Ordinary Shares
Dec 31 2020	BUY Exercise of conversion of derivative security	-	3,056 Added 2.83%	104,947 Ordinary Shares
Nov 30 2020	SELL Payment of exercise price or tax liability	$6,891 $4.6 p/Share	1,498 Reduced 1.45%	101,891 Ordinary Shares
Nov 30 2020	BUY Exercise of conversion of derivative security	-	3,056 Added 2.87%	103,389 Ordinary Shares
Oct 30 2020	SELL Payment of exercise price or tax liability	$7,280 $4.86 p/Share	1,498 Reduced 1.5%	98,471 Ordinary Shares
Oct 30 2020	BUY Exercise of conversion of derivative security	-	3,056 Added 2.97%	99,969 Ordinary Shares
Sep 30 2020	BUY Exercise of conversion of derivative security	-	3,056 Added 3.06%	96,913 Ordinary Shares

Also insider at

CINC

CinCor Pharma, Inc. Healthcare

EVP & Chief Financial Officer

IMPL

IMPEL PHARMACEUTICALS INC Healthcare

CFO

CPRX

CATALYST PHARMACEUTICALS, INC. Healthcare

Executive Vice President & CFO

MWK